Bellevue Group AG Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001674546

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 155 positions · Total reported value $4.20B · Top-10 concentration 41.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.0% · 17 new · 64 cut · 24 exited

Active Share (vs S&P 500): 94.1% · vs QQQ: 96.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $4.20B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2026 13F filing, Bellevue Group AG disclosed 155 equity positions with a combined reported value of $4.20B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 41.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were VRTX ($304.50M), ARGX ($228.57M), REGN ($215.31M). By sector, the heaviest allocations are Health Care 91.9%, Industrials 1.8%. Versus the prior quarter, allocation shifted toward Health Care (+3.4pp) and away from Other (-3.3pp).

Versus the prior quarter, Bellevue Group AG opened 17 new positions, trimmed 64 and fully exited 24, a turnover rate of 61.0% of positions. The portfolio's overlap with the prior quarter was 70% of names.

The largest new positions opened in Q1 2026 were ELVN ($90.98M), PCVX ($69.19M), DMRA ($59.52M).

Of the 24 positions fully exited versus the prior quarter, the largest were RNAM ($189.77M), FOLD ($152.87M), MAZE ($36.78M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • ELVN ENLIVEN THERAPEUTICS INC · $90.98M
  • PCVX VAXCYTE INC · $69.19M
  • DMRA DAMORA THERAPEUTICS INC COM SHS · $59.52M
  • IRON DISC MEDICINE INC · $29.37M
  • ORKA ORUKA THERAPEUTICS INC · $24.87M
  • GLUE MONTE ROSA THERAPEUTICS INC · $20.56M
  • LIVN LIVANOVA PLC · $11.83M
  • RNA ATRIUM THERAPEUTICS INC · $3.52M

Fully Exited (vs previous quarter)

  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $189.77M
  • FOLD AMICUS THERAPEUTICS INC · prev qtr: $152.87M
  • MAZE MAZE THERAPEUTICS INC COM · prev qtr: $36.78M
  • CDNA CAREDX INC · prev qtr: $8.12M
  • MOH MOLINA HEALTHCARE INC · prev qtr: $8.09M
  • ICLR ICON PUB LTD CO · prev qtr: $4.48M
  • BMRN BIOMARIN PHARMACEUTICAL INC · prev qtr: $3.86M
  • BTSG BRIGHTSPRING HEALTH SVCS INC · prev qtr: $3.45M

Insider Transactions (Form 4)

Latest Bellevue Group AG buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Bellevue Group AG files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 148 positions worth $4.75B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 148 positions · $4.75B reported value (Q2 2026)
  • Top 10 holdings = 42.9% of reported value
  • Largest position: AMGN (AMGEN INC) at 6.5%
  • Average position size: $32.11M

Sector Tilt

  • Health Care 92.6%
  • Industrials 1.7%
  • Information Technology 0.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 17 new, 39 added, 64 reduced, 24 exited
  • 28 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 681.91K $304.50M 7.25%
7.25%
Hold
2 313.00K $228.57M 5.44%
5.44%
Reduce
3 278.67K $215.31M 5.12%
5.12%
Add
4 3.58M $176.22M 4.19%
4.19%
Reduce
5 1.17M $163.05M 3.88%
3.88%
Add
6 1.54M $150.20M 3.57%
3.57%
Reduce
7 1.82M $136.56M 3.25%
3.25%
Reduce
8 286.65K $132.14M 3.15%
3.15%
Reduce
9 6.73M $131.56M 3.13%
3.13%
Add
10 481.79K $124.45M 2.96%
2.96%
Add
11 3.28M $119.13M 2.83%
2.83%
Add
12 1.15M $118.24M 2.81%
2.81%
Reduce
13 1.05M $107.91M 2.57%
2.57%
Add
14 295.36K $103.92M 2.47%
2.47%
Add
15 1.47M $92.05M 2.19%
2.19%
Reduce
16 2.32M $90.98M 2.17%
2.17%
New
17 2.80M $84.32M 2.01%
2.01%
Hold
18 957.33K $82.95M 1.97%
1.97%
Add
19 234.54K $77.60M 1.85%
1.85%
Reduce
20 7.80M $77.56M 1.85%
1.85%
Reduce
21 217.24K $71.38M 1.70%
1.70%
Reduce
22 1.19M $69.19M 1.65%
1.65%
New
23 1.71M $68.82M 1.64%
1.64%
Add
24 839.45K $67.22M 1.60%
1.60%
Reduce
25 2.30M $59.52M 1.42%
1.42%
New
26 2.40M $50.21M 1.20%
1.20%
Reduce
27 89.13K $50.08M 1.19%
1.19%
Reduce
28 2.38M $49.86M 1.19%
1.19%
Add
29 788.77K $49.53M 1.18%
1.18%
Reduce
30 3.50M $49.20M 1.17%
1.17%
Add
31 1.53M $48.15M 1.15%
1.15%
Hold
32 148.20K $40.10M 0.95%
0.95%
Reduce
33 202.16K $38.33M 0.91%
0.91%
Add
34 1.20M $38.06M 0.91%
0.91%
Reduce
35 159.35K $35.77M 0.85%
0.85%
Reduce
36 163.66K $34.34M 0.82%
0.82%
Reduce
37 64.41K $31.66M 0.75%
0.75%
Reduce
38 33.93K $31.21M 0.74%
0.74%
Hold
39 416.89K $29.67M 0.71%
0.71%
Reduce
40 459.31K $29.37M 0.70%
0.70%
New
41 119.10K $29.11M 0.69%
0.69%
Reduce
42 5.16M $28.57M 0.68%
0.68%
Hold
43 98.26K $26.21M 0.62%
0.62%
Reduce
44 507.01K $24.87M 0.59%
0.59%
New
45 206.59K $24.85M 0.59%
0.59%
Add
46 139.68K $23.95M 0.57%
0.57%
Reduce
47 99.88K $22.09M 0.53%
0.53%
Reduce
48 247.26K $21.30M 0.51%
0.51%
Reduce
49 1.25M $20.56M 0.49%
0.49%
New
50 93.57K $20.35M 0.48%
0.48%
Reduce

FAQ

What did Bellevue Group AG buy in 2026-Q1?

In its 2026-Q1 13F filing, Bellevue Group AG reported 155 equity positions worth $4.20B in aggregate; its largest disclosed positions were VRTX ($304.50M), ARGX ($228.57M), REGN ($215.31M).

How large is Bellevue Group AG's portfolio?

Bellevue Group AG reported $4.20B of long equity holdings across 155 positions as of 2026-Q1. Top-10 holdings account for 41.9% of reported value.

What is Bellevue Group AG's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bellevue-group-ag/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →